Prostate cancer blood test 'helps target treatment'

Prostate cancer blood test 'helps target treatment'

Scientists have developed a blood test that could pick out which men with advanced prostate cancer would benefit from a new drug treatment. The test detects cancer DNA in the blood, helping doctors check whether precision drugs are working. Cancer Research UK said the test could “greatly improve survival”. But larger studies involving more men needed to take place to confirm if doctors could rely on the test, the charity said. Blood samples from 49…

Read More

Drug that creates a 'real sun-tan' could prevent cancer

Drug that creates a 'real sun-tan' could prevent cancer

Scientists have developed a drug that mimics sunlight to make the skin tan, with no damaging UV radiation involved. The drug tricks the skin into producing the brown form of the pigment melanin in tests on skin samples and mice. Evidence suggests it will work even on redheads, who normally just burn in the sun. The team at Massachusetts General Hospital hope their discovery could prevent skin cancer and even slow the appearance of ageing….

Read More

Boobs and Brass: The female band raising cash for breast cancer

Boobs and Brass: The female band raising cash for breast cancer

In 2006, two friends decided to break the male dominance of the brass band world by forming an all-female band – and called it Boobs and Brass. Eleven years on, they have raised £200,000 for charity and have more than 600 members across the UK. On Friday, Boobs and Brass was given the BBC Music Day Brass Band Award, for the band that best embodies the BBC Music Day 2017 theme – “the power of…

Read More

Prostate cancer treatment 'could help more patients'

Prostate cancer treatment 'could help more patients'

One of the largest clinical trials for prostate cancer has given “powerful results”, say UK researchers. A drug for treating prostate cancer that has spread was found to save lives when offered earlier, a study found. The trial looked at abiraterone as an additional treatment in patients with prostate cancer who were about to start long-term hormone therapy. Abiraterone improved survival, according to results published in the New England Journal of Medicine. Prof Nicholas James,…

Read More

'Half a glass of wine every day' increases breast cancer risk

'Half a glass of wine every day' increases breast cancer risk

Further evidence has emerged of the link between alcohol consumption in women and an increased risk of breast cancer. According to a report from the World Cancer Research Fund, half a glass of wine or a small beer a day increases the risk of breast cancer. It also backs up research showing that regular intensive exercise can reduce the risk of the disease. But is it really that simple? Breast cancer is by far the…

Read More

Cancer drug price hike company investigated

Cancer drug price hike company investigated

The European Commission has launched an investigation into claims that drug company Aspen Pharma excessively increased prices of five life-saving cancer medicines. The drugs include chlorambucil and busulfan – used to treat leukaemia. The Commission said it was looking at claims that Aspen imposed “very significant and unjustified” price hikes. The company confirmed an investigation was under way. Patents expired In a statement, Aspen said it was not currently in a position to comment on…

Read More

Johnson & Johnson ordered to pay $110m in US talc cancer case

Johnson & Johnson ordered to pay $110m in US talc cancer case

Pharmaceutical firm Johnson & Johnson (J&J) has been ordered by a US court to pay more than $ 110m (£85m) to a woman who says she developed ovarian cancer after using its talcum powder. Lois Slemp, 62, from Virginia, Missouri said she developed the cancer after four decades of using talc products. Prosecutors argued the company did not adequately warn about the cancer risks associated with the items. Experts say links with ovarian cancer are…

Read More

Prostate cancer: Blood test could help target treatment

Prostate cancer: Blood test could help target treatment

A blood test has been developed that could help target treatment for men with advanced prostate cancer. Cancer researchers in Europe analysed blood from 265 men with the disease. They found those with multiple copies of a particular gene did not respond to abiraterone and enzalutamide – drugs commonly used to treat advanced cases. More trials are needed but the team hope the test could prevent thousands of men undergoing unnecessary treatment and allow more…

Read More
1 2 3 6